Experienced in Attention Deficit Hyperactivity Disorder (ADHD)

Adrian J. Dunlop

1 University Drive, 
Callaghan, NSW, AU 
Experienced in Attention Deficit Hyperactivity Disorder (ADHD)
1 University Drive, 
Callaghan, NSW, AU 
OverviewLocationsClinical Research

Overview

Adrian Dunlop practices in Callaghan, Australia. Mr. Dunlop is rated as an Experienced expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). His top areas of expertise are Hepatitis C, Opioid Use Disorder, Hepatitis, and Chronic Pain.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Attention Deficit Hyperactivity Disorder (ADHD).

Gender
Male

Locations

1 University Drive, Callaghan, NSW 2308, Australia
Other Locations
University Drive, Callaghan, NSW 2308, Australia
670 Hunter Street, Newcastle West, NSW 2302, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase IV, Open-label, Single Arm, Multicentre Trial of Grazoprevir/Elbasvir for Genotype 1 or 4 in People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use or Receiving Opioid Substitution Therapy
A Phase IV, Open-label, Single Arm, Multicentre Trial of Grazoprevir/Elbasvir for Genotype 1 or 4 in People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use or Receiving Opioid Substitution Therapy
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 4

174 Total Publications

Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence.
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence.
Journal: Pain management
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dunlop's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile